331. Altman С. Hepatic toxicity of antitubercular agents. Role of different
drugs / C. Altman, M. Biour, J.D. Grange // Presse. Med. - 1993. - Vol. 22, № 26.
P 1212-1216.
332. Alvirez-Freiter E.J. In vitro activities of several fluoroquinolones
against Mycjbacterium tuberculosis / E.J. Alvirez-Freiter, M.N. Cynamon // 9th
Intern. Congr. Inf. Dis., Buenos Aires, 2000. - Abstracts. - № 75.015.
333. Armas P.L., Gonsales O.F. The management of tuberculosis in the
Republic o f Cuba / P.L. Armas, O.F. Gonsales // Rev. Cubana Med. trop. - 1998.
Vol. 50, № 2 . - P . 150-158.
334. Arrizabalaga P. Hypocalcemia, hypomagnesemia and hypokaliemia
induced by capreomycin / P. Arrizabalaga, M. Domingo, J. Montoliu et al. // Med.
Clin. (Bare). - 1983. -V o l . 80, №9. - P . 413-415.
335. Ball P. Efficacy and safety of levofloxacin in the context of other
contemporary fluoroquinolones: a review / P Ball // Curr. Ther. Res. - 2003. -
Vol. 6, № 9 . - P . 646-661.
336. Ball P.
Quinolone-induced QT interval prolongation: a not
sounexpected class effect / P. Ball // J. Anthimicrob. Chemother. - 2000. - № 15. -
P 557-559.
337. Ballow C. Absolute biovailability of moxifloxacin / C. Ballow, J.
Lettiere, V Agarval et al. // Clin. Ther. - 1999. - Vol. 21. - P. 513-522.
338. Barakovic F. Dysfunction of the left chamber after myocardial infarct /
F Baracovic, Z. Kusljogic, E. Smajic et al. // Med. Arh. - 2004. - Vol. 58. - P.
145-147.
339. Bemardi L. Evidence for an intrinsic mechanism regulating heart rate
variability in the transplanted and the intact heart during submaximal dynamic
exercise? / L. Bemardi, F. Salvucci, R. Suardi // Cardiovasc. Res. - 1990. - Vol.
2 4 .- P . 969-981.
340. Beming S.E. The role of fluoroquinolones in tuberculosis today / S.E.
Berning // Drugs. - 2001. - Vol. 61, № 1. - P. 9-18.
393
